Balchem Statistics
Total Valuation
Balchem has a market cap or net worth of $5.38 billion. The enterprise value is $5.55 billion.
| Market Cap | 5.38B |
| Enterprise Value | 5.55B |
Important Dates
The next estimated earnings date is Friday, February 14, 2025, before market open.
| Earnings Date | Feb 14, 2025 |
| Ex-Dividend Date | Dec 28, 2023 |
Share Statistics
Balchem has 32.51 million shares outstanding. The number of shares has increased by 0.63% in one year.
| Current Share Class | 32.51M |
| Shares Outstanding | 32.51M |
| Shares Change (YoY) | +0.63% |
| Shares Change (QoQ) | +0.41% |
| Owned by Insiders (%) | 0.71% |
| Owned by Institutions (%) | 90.11% |
| Float | 32.26M |
Valuation Ratios
The trailing PE ratio is 44.36 and the forward PE ratio is 34.84. Balchem's PEG ratio is 3.87.
| PE Ratio | 44.36 |
| Forward PE | 34.84 |
| PS Ratio | 5.67 |
| Forward PS | 5.24 |
| PB Ratio | 4.57 |
| P/TBV Ratio | 24.61 |
| P/FCF Ratio | 33.12 |
| P/OCF Ratio | 27.30 |
| PEG Ratio | 3.87 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 25.81, with an EV/FCF ratio of 34.18.
| EV / Earnings | 45.67 |
| EV / Sales | 5.89 |
| EV / EBITDA | 25.81 |
| EV / EBIT | 33.80 |
| EV / FCF | 34.18 |
Financial Position
The company has a current ratio of 2.98, with a Debt / Equity ratio of 0.21.
| Current Ratio | 2.98 |
| Quick Ratio | 1.77 |
| Debt / Equity | 0.21 |
| Debt / EBITDA | 1.11 |
| Debt / FCF | 1.51 |
| Interest Coverage | 8.64 |
Financial Efficiency
Return on equity (ROE) is 11.04% and return on invested capital (ROIC) is 7.21%.
| Return on Equity (ROE) | 11.04% |
| Return on Assets (ROA) | 6.41% |
| Return on Capital (ROIC) | 7.21% |
| Revenue Per Employee | $723,793 |
| Profits Per Employee | $93,349 |
| Employee Count | 1,302 |
| Asset Turnover | 0.59 |
| Inventory Turnover | 5.26 |
Taxes
In the past 12 months, Balchem has paid $33.70 million in taxes.
| Income Tax | 33.70M |
| Effective Tax Rate | 21.71% |
Stock Price Statistics
The stock price has increased by +14.00% in the last 52 weeks. The beta is 0.67, so Balchem's price volatility has been lower than the market average.
| Beta (5Y) | 0.67 |
| 52-Week Price Change | +14.00% |
| 50-Day Moving Average | 174.85 |
| 200-Day Moving Average | 164.16 |
| Relative Strength Index (RSI) | 30.80 |
| Average Volume (20 Days) | 148,365 |
Short Selling Information
The latest short interest is 436,616, so 1.34% of the outstanding shares have been sold short.
| Short Interest | 436,616 |
| Short Previous Month | 490,274 |
| Short % of Shares Out | 1.34% |
| Short % of Float | 1.35% |
| Short Ratio (days to cover) | 3.13 |
Income Statement
In the last 12 months, Balchem had revenue of $942.38 million and earned $121.54 million in profits. Earnings per share was $3.73.
| Revenue | 942.38M |
| Gross Profit | 324.86M |
| Operating Income | 164.24M |
| Pretax Income | 147.82M |
| Net Income | 121.54M |
| EBITDA | 215.09M |
| EBIT | 164.24M |
| Earnings Per Share (EPS) | $3.73 |
Balance Sheet
The company has $73.69 million in cash and $245.29 million in debt, giving a net cash position of -$171.60 million or -$5.28 per share.
| Cash & Cash Equivalents | 73.69M |
| Total Debt | 245.29M |
| Net Cash | -171.60M |
| Net Cash Per Share | -$5.28 |
| Equity (Book Value) | 1.18B |
| Book Value Per Share | 36.21 |
| Working Capital | 216.55M |
Cash Flow
In the last 12 months, operating cash flow was $197.09 million and capital expenditures -$34.65 million, giving a free cash flow of $162.44 million.
| Operating Cash Flow | 197.09M |
| Capital Expenditures | -34.65M |
| Free Cash Flow | 162.44M |
| FCF Per Share | $5.00 |
Margins
Gross margin is 34.47%, with operating and profit margins of 17.43% and 12.90%.
| Gross Margin | 34.47% |
| Operating Margin | 17.43% |
| Pretax Margin | 16.47% |
| Profit Margin | 12.90% |
| EBITDA Margin | 22.82% |
| EBIT Margin | 17.43% |
| FCF Margin | 17.24% |
Dividends & Yields
This stock pays an annual dividend of $1.19, which amounts to a dividend yield of 0.72%.
| Dividend Per Share | $1.19 |
| Dividend Yield | 0.72% |
| Dividend Growth (YoY) | 67.38% |
| Years of Dividend Growth | 14 |
| Payout Ratio | 31.85% |
| Buyback Yield | -0.63% |
| Shareholder Yield | 0.09% |
| Earnings Yield | 2.26% |
| FCF Yield | 3.02% |
Analyst Forecast
The average price target for Balchem is $190.00, which is 14.81% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $190.00 |
| Price Target Difference | 14.81% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on January 21, 2010. It was a forward split with a ratio of 1.5:1.
| Last Split Date | Jan 21, 2010 |
| Split Type | Forward |
| Split Ratio | 1.5:1 |
Scores
Balchem has an Altman Z-Score of 8.86 and a Piotroski F-Score of 7.
| Altman Z-Score | 8.86 |
| Piotroski F-Score | 7 |